Tempus AI Expands “Tempus Next” Platform to Improve Breast Cancer Care with AI-Driven Insights.

Tempus AI Inc. (NASDAQ:TEM) is one of the best young stocks to buy and hold for 5 years. On July 8, Tempus AI announced the expansion of its care pathway intelligence platform, called Tempus Next, to include breast cancer. Launched in 2024, Tempus Next has already screened thousands of patients and helped close critical care […]